|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 12-08-02 | Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading | RE |
| 12-07-16 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes |
|---|
Basic data
Market Cap (USD)
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 0 | ||
| +0.61% | +2.88% | +45.63% | +0.39% | 82.73B | ||
| -0.12% | +4.13% | -19.43% | -35.31% | 57.94B | ||
| +14.36% | +152.27% | +526.55% | +41.90% | 55.45B | ||
| +0.76% | +3.53% | +0.08% | +36.18% | 52.57B | ||
| +1.86% | +3.13% | +11.49% | +174.36% | 48.94B | ||
| +1.21% | +3.87% | +61.90% | -16.51% | 32.23B | ||
| +1.36% | +5.06% | +53.04% | +103.13% | 25.94B | ||
| +9.69% | +11.45% | +14.36% | +215.11% | 22.1B | ||
| +3.89% | +1.08% | +61.82% | +112.10% | 16.55B | ||
| Average | +3.70% | +22.11% | +83.94% | +70.15% | 39.44B | |
| Weighted average by Cap. | +3.33% | +27.39% | +94.12% | +49.43% |
Historical Quotes: Amylin Pharmaceuticals LLC
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- Stock
- Quotes Amylin Pharmaceuticals LLC
Select your edition
All financial news and data tailored to specific country editions
















